Galera Therapeutics, Inc.
SEC Filing List
GRTX CIK: 0001563577
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D | Toppan Merrill/FA | 06/11/2026 | |||
| 425 | Filing under Securities Act Rule 425 of ... | Galera Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/02/2026 | |
| 425 | Filing under Securities Act Rule 425 of ... | Galera Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/02/2026 | |
| SCHEDULE 13D/A | HOGAN LOVELLS US LLP /fa | 05/29/2026 | |||
| 4 | Statement of changes in beneficial owner... | HOGAN LOVELLS US LLP /fa | 05/29/2026 | ||
| 425 | Filing under Securities Act Rule 425 of ... | Galera Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/22/2026 | |
| 425 | Filing under Securities Act Rule 425 of ... | Galera Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/21/2026 | |
| 8-K | Current report filing | Galera Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/19/2026 | |
| 8-K | Current report filing | Galera Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Galera Therapeutics, Inc. | 05/14/2026 | ||
| No record found. | |||||
| Load More | |||||
